Insider filing · PGEN
Jeffrey B Kindler
Director
profile →
Precigen, Inc.
PGEN · Healthcare · 21 filings in 24 months
ticker →
Jeffrey B Kindler sold $1.4M of Precigen (PGEN)
Executed Aug 26, disclosed Aug 29, 2 days later.
Value, as filed
$1.4M
185,000 sh × $7.44
Executed
Aug 26
the trade date, as filed
Disclosed
Aug 29
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JKJeffrey B Kindler (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Precigen, Inc. (PGEN). The largest single filing was $1.4M of PGEN (185,000 sh × $7.44, as filed), executed Aug 26.
The name
PGENHealthcare · Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to tar…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jeffrey B Kindler in PGEN
PGENSALE
Precigen, Inc.
$855K235,467 sh × $3.63
Exec Dec 12 2025
Filed Dec 16 2025 · 5:30 PM ET PGENSALE Precigen, Inc. $604K
174,360 sh across 2 lots
Exec Sep 29 2025
Filed Oct 1 2025 · 5:30 PM ET